FILE:HCP/HCP-8K-20070201154849.txt.gz
EVENTS:	Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
TEXT:
ITEM: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
HEALTH CARE PROPERTY INVESTORS, INC.
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 240.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
o
 
 
Item 5.02  Departure of Directors or Principal Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On January 26, 2007, the Compensation Committee of the Board of Directors (the "Compensation Committee") of Health Care Property Investors, Inc. (the "Company") increased the annual base salary rates for certain of the Company's named executive officers, with the new rates effective as of January 1, 2007. The new annual base salary rates for James F. Flaherty III, President and Chief Executive Officer, Paul F. Gallagher, Executive Vice President  Chief Investment Officer, Stephen R. Maulbetsch, Executive Vice President  Strategic Development, and Mark A. Wallace, Executive Vice President  Chief Financial Officer and Treasurer, are $600,000, $350,000, $350,000 and $350,000 respectively.
In addition, the Compensation Committee approved annual incentive bonuses for the 2006 fiscal year for the Company's named executive officers, based upon multiple performance criteria, including subjective evaluations of personal job performance and performance measured against objective business criteria.  The 2006 annual cash incentive bonus amounts for the Company's named executive officers are as follows:  Mr. Flaherty, $0 (see the restricted stock unit discussion below), Charles A. Elcan, Executive Vice President - Medical Office Properties, $355,000, Mr. Gallagher, $475,000, Mr. Maulbetsch, $425,000, and Mr. Wallace, $390,000.
On January 26, 2007, the Compensation Committee approved the grant of 113,200 performance-based Restricted Stock Units to Mr. Flaherty in lieu of a cash bonus for 2006 performance.  The Restricted Stock Units are subject in whole or in part to forfeiture in the event the Company does not reach specified targets for funds from operations per share during fiscal 2007.  Those Restricted Stock Units that are not forfeited vest on the third anniversary of the date of grant, subject to continued employment by Mr. Flaherty through that date and subject to accelerated vesting in connection with certain terminations of employment in accordance with Mr. Flaherty's employment agreement with the Company.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 


